Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-15-000323

← back to feed
Filed
Aug 13, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 13, 2015 15.43M sh
Shares Diluted Q2 2015 · Jun 30, 2015 15.37M sh
Shares Diluted Q2 2015 · Jun 30, 2015 15.32M sh
Shares Diluted Q2 2015 · Jun 30, 2014 16.27M sh
Shares Diluted Q2 2015 · Jun 30, 2014 14.61M sh
Stockholders Equity Q2 2015 · Jun 30, 2015 −$68.89K
Stockholders Equity Q2 2015 · Dec 31, 2014 $63.6K
Current Liabilities Q2 2015 · Jun 30, 2015 $122.32K
Current Liabilities Q2 2015 · Dec 31, 2014 $242.21K
Total Liabilities Q2 2015 · Jun 30, 2015 $148.32K
Total Liabilities Q2 2015 · Dec 31, 2014 $268.21K
Current Assets Q2 2015 · Jun 30, 2015 $45.15K
Current Assets Q2 2015 · Dec 31, 2014 $322.93K
Total Assets Q2 2015 · Jun 30, 2015 $79.43K
Total Assets Q2 2015 · Dec 31, 2014 $331.82K
Capex Q2 2015 · Jun 30, 2014 $3.53K
Operating Cash Flow Q2 2015 · Jun 30, 2014 −$307.29K
Cash And Equivalents Q2 2015 · Jun 30, 2014 $379.95K
Cash And Equivalents Q2 2015 · Dec 31, 2013 $18.99K
Sga Expense Q2 2015 · Jun 30, 2014 $276.56K
Sga Expense Q2 2015 · Jun 30, 2014 $452.93K
Rd Expense Q2 2015 · Jun 30, 2014 $50.22K
Rd Expense Q2 2015 · Jun 30, 2014 $64.45K
Net Income restated Q2 2015 · Jun 30, 2014 −$328.38K
Net Income Q2 2015 · Jun 30, 2014 −$520.84K
Operating Income Q2 2015 · Jun 30, 2014 −$327.38K
Operating Income Q2 2015 · Jun 30, 2014 −$518.71K